These results suggest that crosstalk between kinases and PRMT5 may play a pivotal role in modulating the diverse cellular functions of PRMT5, implicating the potential utility of relevant kinase inhibitors to disrupt PRMT5-NF-κB cooperativity and impede cancer cell growth. The gene discussed is PRMT5; the disease is cancer.